| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yuan Liu, Anyin Feng, Shi Zhao, Weiming Wang, Daihai H. Large-scale synchronized replacement of Alpha (B.1.1.7) variant by the Delta (B.1.617.2) variant of SARS-COV-2 in the COVID-19 pandemic. Mathematical biosciences and engineering : MBE. vol 19. issue 4. 2022-03-28. PMID:35341265. |
large-scale synchronized replacement of alpha (b.1.1.7) variant by the delta (b.1.617.2) variant of sars-cov-2 in the covid-19 pandemic. |
2022-03-28 |
2023-08-13 |
Not clear |
| Yuan Liu, Anyin Feng, Shi Zhao, Weiming Wang, Daihai H. Large-scale synchronized replacement of Alpha (B.1.1.7) variant by the Delta (B.1.617.2) variant of SARS-COV-2 in the COVID-19 pandemic. Mathematical biosciences and engineering : MBE. vol 19. issue 4. 2022-03-28. PMID:35341265. |
in this work, we report a large-scale synchronized replacement pattern of the alpha (b.1.1.7) variant by the delta (b.1.617.2) variant of sars-cov-2. |
2022-03-28 |
2023-08-13 |
Not clear |
| Mikako Ueno, Naoko Iwata-Yoshikawa, Akihito Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida, Isao Yoshida, Mami Nagashima, Hiroyuki Asakura, Yuu I Yaoita, Jun Suzuki, Kenji Sadamasu, Kazuhisa Yoshimura, Satoshi Kutsuna, Nozomi Shiwa-Sudo, Noriyo Nagata, Tadaki Suzuki, Akinori Suzuki, Miwa Okamoto, Moto Kimura, Norio Ohmagari, Ryu Miura, Yukihito Ishizak. Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants. Antiviral research. 2022-03-28. PMID:35341809. |
ev053273 exerted potent antiviral activity against the wunan wild-type virus as well as the alpha and delta variants in vitro, whereas the antiviral activity of ev053286 was moderate, but it had a wide-range of suppressive activity on the wild-type virus as well as the alpha, beta, delta, kappa, omicron ba.1, and ba.2 variants. |
2022-03-28 |
2023-08-13 |
mouse |
| Manli Zhang, Lars Riecke, Gorka Fraga-González, Milene Bont. Altered brain network topology during speech tracking in developmental dyslexia. NeuroImage. 2022-03-28. PMID:35342007. |
the network topology of the phase synchronization of evoked cortical oscillations was investigated in four frequency bands (delta, theta, alpha and beta) using minimum spanning tree graphs. |
2022-03-28 |
2023-08-13 |
Not clear |
| Pallab Kar, Md Moshfekus Saleh-E-In, Nishika Jaishee, Akash Anandraj, Emil Kormuth, Balachandar Vellingiri, Claudio Angione, Pattanathu K S M Rahman, Suntheren Pillay, Arnab Sen, Devashan Naidoo, Ayan Roy, Yong E Cho. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19. Journal of cellular biochemistry. 2022-03-28. PMID:35342986. |
in this study, we explored the inhibitory potential of a library of 605 phytocompounds, selected from indian medicinal plants with reported antiviral and anti-inflammatory activities, against the receptor-binding domain of spike proteins of the sars-cov-2 wild-type and the variants of concern, including variants b.1.1.7 (alpha), b.1.351 (beta), p.1 (gamma), b.1.617.2 (delta), and b.1.1.529 (omicron). |
2022-03-28 |
2023-08-13 |
human |
| Evangelos Kontopodis, Vasileios Pierros, Dimitrios J Stravopodis, George T Tsangari. Prediction of SARS-CoV-2 Omicron Variant Immunogenicity, Immune Escape and Pathogenicity, through the Analysis of Spike Protein-Specific Core Unique Peptides. Vaccines. vol 10. issue 3. 2022-03-26. PMID:35334990. |
in this study, we identified the core unique peptides (crups) that reside exclusively in the omicron variant of spike protein and are absent from the human proteome, creating a new dataset of peptides named as sars-cov-2 crups against the human proteome (c/h-crups), and we analyzed their locations in comparison to the alpha and delta variants. |
2022-03-26 |
2023-08-13 |
human |
| Marco Fabiani, Katia Margiotti, Manuela Sabatino, Antonella Viola, Alvaro Mesoraca, Claudio Giorlandin. A Rapid and Consistent Method to Identify Four SARS-CoV-2 Variants during the First Half of 2021 by RT-PCR. Vaccines. vol 10. issue 3. 2022-03-26. PMID:35335115. |
several vocs have been detected, including alpha variant (b.1.1.7), beta variant (b.1.351), gamma variant (p.1/b.1.1.28.1) and delta variant (b.1.617.2), first identified in the uk, south africa, brazil and india, respectively. |
2022-03-26 |
2023-08-13 |
Not clear |
| Jing Pu, Xiaoyang He, Wei Xu, Cong Wang, Qiaoshuai Lan, Chen Hua, Kai Wang, Lu Lu, Shibo Jian. The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its Variants. Viruses. vol 14. issue 3. 2022-03-26. PMID:35336896. |
here, we report a series of small-molecule compounds that proved effective against human coronaviruses (hcov), such as sars-cov-2 and its variants of concern (vocs), including alpha (b.1.1.7), beta (b.1.351), gamma (p.1), delta (b.1.617.2), and omicron (b.1.1.529), sars-cov, mers-cov, hcov-oc43, and other viruses with class i viral fusion proteins, such as influenza virus, ebola virus (ebov), nipah virus (niv), and lassa fever virus (lasv). |
2022-03-26 |
2023-08-13 |
human |
| Anissa Chouikha, Wasfi Fares, Asma Laamari, Sondes Haddad-Boubaker, Zeineb Belaiba, Kais Ghedira, Wafa Kammoun Rebai, Kaouther Ayouni, Marwa Khedhiri, Samar Ben Halima, Henda Krichen, Henda Touzi, Imen Ben Dhifallah, Fatma Z Guerfali, Chiraz Atri, Saifeddine Azouz, Oussema Khamessi, Monia Ardhaoui, Mouna Safer, Nissaf Ben Alaya, Ikram Guizani, Rym Kefi, Mariem Gdoura, Henda Trik. Molecular Epidemiology of SARS-CoV-2 in Tunisia (North Africa) through Several Successive Waves of COVID-19. Viruses. vol 14. issue 3. 2022-03-26. PMID:35337031. |
during the second wave, a large number of lineages were detected; the third wave was marked by the predominance of the alpha voc, and the fourth wave was characterized by the predominance of the delta voc. |
2022-03-26 |
2023-08-13 |
Not clear |
| Seon Beom Kim, Mary Zoepfl, Priyanka Samanta, Fuming Zhang, Ke Xia, Reena Thara, Robert J Linhardt, Robert J Doerksen, Michael A McVoy, Vitor H Pomi. Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties. The Journal of biological chemistry. 2022-03-26. PMID:35337800. |
we observed distinct affinities of bosg derivatives for the s-proteins of different sars-cov-2 strains, including wild type, n501y (alpha), k417t/e484k/n501y (gamma), and l542r (delta) mutants, and stronger affinity for the n501y-containing variants. |
2022-03-26 |
2023-08-13 |
Not clear |
| Diego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, David A Wells, George W Carnell, Luis Ohlendorf, Matteo Ferrari, Phil Palmer, Andrew C Y Chan, Peter Smith, Emma M Bentley, Sebastian Einhauser, Ralf Wagner, Mark Page, Gianmarco Raddi, Helen Baxendale, Javier Castillo-Olivares, Jonathan Heeney, Nigel Temperto. Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds. Frontiers in immunology. vol 13. 2022-03-25. PMID:35330908. |
using pseudotyped virus, we examine the capacity of convalescent sera, from a well-defined cohort of healthcare workers (hcw) and patients infected during the first wave from a national critical care centre in the uk to neutralise b.1.1.298, variants of interest (voi) b.1.617.1 (kappa), and four vocs, b.1.1.7 (alpha), b.1.351 (beta), p.1 (gamma) and b.1.617.2 (delta), including the b.1.617.2 k417n, informally known as delta plus. |
2022-03-25 |
2023-08-13 |
Not clear |
| Qi Chen, Xing-Yao Huang, Yu Liu, Meng-Xu Sun, Bin Ji, Chao Zhou, Hang Chi, Rong-Rong Zhang, Dan Luo, Ying Tian, Xiao-Feng Li, Zhao Hui, Cheng-Feng Qi. Comparative characterization of SARS-CoV-2 variants of concern and mouse-adapted strains in mice. Journal of medical virology. 2022-03-24. PMID:35322439. |
in this study, we systematically investigated the infectivity and pathogenicity of three vocs, alpha, beta and delta, in mice in comparison with two well-understood sars-cov-2 mouse-adapted strains, mascp6 and mascp36，sharing key mutations in receptor binding domain (rbd) with alpha or beta, respectively. |
2022-03-24 |
2023-08-13 |
mouse |
| Qi Chen, Xing-Yao Huang, Yu Liu, Meng-Xu Sun, Bin Ji, Chao Zhou, Hang Chi, Rong-Rong Zhang, Dan Luo, Ying Tian, Xiao-Feng Li, Zhao Hui, Cheng-Feng Qi. Comparative characterization of SARS-CoV-2 variants of concern and mouse-adapted strains in mice. Journal of medical virology. 2022-03-24. PMID:35322439. |
our results showed that the beta variant had the strongest infectivity and pathogenicity among the three vocs, while delta variant only caused limited replication and mild pathogenic changes in mouse lung, which is much weaker than alpha variant did. |
2022-03-24 |
2023-08-13 |
mouse |
| Victor Férat, Martin Seeber, Christoph M Michel, Tomas Ro. Beyond broadband: Towards a spectral decomposition of electroencephalography microstates. Human brain mapping. 2022-03-24. PMID:35324021. |
in this study, using a large open-access dataset (n = 203), we first filtered eeg recordings into four classical frequency bands (delta, theta, alpha and beta) and thereafter compared their individual ms segmentations using mutual information as well as traditional ms measures (e.g., mean duration and time coverage). |
2022-03-24 |
2023-08-13 |
Not clear |
| Mark W Tenforde, Wesley H Self, Manjusha Gaglani, Adit A Ginde, David J Douin, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Tresa McNeal, Shekhar Ghamande, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Anne E Frosch, Michelle N Gong, Amira Mohamed, Nicholas J Johnson, Vasisht Srinivasan, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Akram Khan, Catherine L Hough, Laurence W Busse, Abhijit Duggal, Jennifer G Wilson, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, Matthew C Exline, Mena Botros, Adam S Lauring, Nathan I Shapiro, Natasha Halasa, James D Chappell, Carlos G Grijalva, Todd W Rice, Ian D Jones, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Jillian P Rhoads, Christopher J Lindsell, Kimberly W Hart, Yuwei Zhu, Katherine Adams, Diya Surie, Meredith L McMorrow, Manish M Pate. Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022. MMWR. Morbidity and mortality weekly report. vol 71. issue 12. 2022-03-24. PMID:35324878. |
during this period, the most commonly circulating variants of sars-cov-2, the virus that causes covid-19, were b.1.1.7 (alpha), b.1.617.2 (delta), and b.1.1.529 (omicron). |
2022-03-24 |
2023-08-13 |
Not clear |
| Bingchen Yu, Shanshan Li, Takako Tabata, Nanxi Wang, G Renuka Kumar, Jun Liu, Melanie M Ott, Lei Wan. Accelerating PERx Reaction Enables Covalent Nanobodies for Potent Neutralization of SARS-Cov-2 and Variants. bioRxiv : the preprint server for biology. 2022-03-22. PMID:35313590. |
in comparison with the noncovalent wildtype nanobody, the ffy-incorporated covalent nanobody neutralized both authentic sars-cov-2 and its alpha and delta variants with potency drastically increased over tens of folds. |
2022-03-22 |
2023-08-13 |
Not clear |
| Karan Pattni, Daniel Hungerford, Sarah Adams, Iain Buchan, Christopher P Cheyne, Marta García-Fiñana, Ian Hall, David M Hughes, Christopher E Overton, Xingna Zhang, Kieran J Sharke. Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2. BMC infectious diseases. vol 22. issue 1. 2022-03-21. PMID:35307024. |
prior to the delta variant, most vaccine effectiveness studies focused on the alpha variant. |
2022-03-21 |
2023-08-13 |
Not clear |
| Andrea T Cruz, Mark R Deniso. Integrating SARS-CoV-2 Antibody Results in Children into Pandemic Response. Pediatrics. 2022-03-18. PMID:35301523. |
the authors found that, in this cohort of 218 children, approximately 45% had antibodies to the nucleocapsid protein during the time that the predominant circulating variants were alpha and delta. |
2022-03-18 |
2023-08-13 |
Not clear |
| Sarah E Messiah, Stacia DeSantis, Luis Leon-Novelo, Yashar Talebi, Frances Brito, Harold W Kohl Iii, Melissa Valerio-Shewmaker, Jessica Ross, Michael D Swartz, Ashraf Yaseen, Steven H Kelder, Shiming Zhang, Onyinye S Omega-Njemnobi, Michael O Gonzalez, Leqing Wu, Eric Boerwinkle, David Lakey, Jennifer A Shuford, Stephen J Pon. Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents. Pediatrics. 2022-03-18. PMID:35301530. |
as of january 27, 2022 over 11.4 million children in the united states (us) have tested positive for covid-19.1 covid-19 cases among us children have seen an exponential increase in december 2021 and january 2022, a very short time period that far exceeds previous peaks of infection.1 these recent data suggest the omicron (b.1.1.529) variant is more transmissible compared to the delta (b.1.617.2) and alpha (b.1.1.7) variants.1 these data are particularly troubling as they coincide with school re-openings after the 2021-22 holiday break across the country. |
2022-03-18 |
2023-08-13 |
Not clear |
| Qixin Leng, A James Mixso. Novel Method for Rapid Detection of COVID-19 Omicron Variant and Future Emerging Variants. Discovery medicine. vol 33. issue 168. 2022-03-16. PMID:35292130. |
several major and minor variant waves of covid-19 including the alpha (b.1.1.7), delta (b.1.617.2), and the omicron (b.1.1.529) have infected patients in the last two years. |
2022-03-16 |
2023-08-13 |
Not clear |